The number of available treatments for the symptoms ofscleroderma is increasing while the need for dermatologists to investigateorgan involvement is also on the rise
Federal Trade Commission Votes to Ban Noncompete Clauses Between Employers and Workers
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
US Central and European Commands Should Revisit Disallowance of Systemic Treatments for Deployed Individuals With Psoriasis, Eczema, Paper Argues
ReV Up Your Vitiligo Treatment Strategies
ASLAN Announces Positive Phase 2 Results of Eblasakimab in Dupilumab-Treated Patients With AD
Jessner’s Lymphocytic Infiltration of the Skin Mimicking Rosacea: A Rare Case Presentation